Status: Recruiting
Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Very high-risk acute lymphoblastic leukemia
Participants needed: 74
Trial details
Phase: Phase 2Age: 1-19Biological sex: AllType: InterventionalSponsor: Hyoung Jin KangUpdated: Jun 8, 2025Locations: 6
Eligibility criteria
Philadelphia chromosome-positive t(9;22)(q34;q11) or [+4]
Participants with contraindications to medications [+3]